生物信息学
墨西哥利什曼原虫
细胞内
无鞭毛体
利什曼原虫
化学
生物化学
生物活性
药理学
药物发现
生物
药品
杜氏利什曼原虫
利什曼病
作用机理
喹啉
细胞器
体外
流出
结构-活动关系
IC50型
铅化合物
数量结构-活动关系
效力
细胞内寄生虫
线粒体
分泌物
作者
Angelo Gelvez,Liesangerli Labrador-Fagúndez,Bruno G. Stella,Sugeins Rivero,Yaniska Ramirez,Thalia Vidal,Nathalia Martinez-Sotillo,Alirica Isabel Suarez,Katiuska E. Chávez,Hégira Ramírez,Zuleyma Blanco,Joyce E. Gutiérrez,Jaime Charris,Gustavo Benaím
摘要
Leishmaniasis is a parasitic human infection that constitutes a major global health challenge due to limited therapeutic options, toxicity, resistance, and high costs of the drugs approved as therapy. In this study, a group of 7‐chloroquinoline derivatives ( 5 – 12 ) was synthesized via an optimized route and evaluated against the human parasite Leishmania mexicana . Compounds were fully characterized and showed favorable in silico ADME/Tox profiles, including high predicted gastrointestinal absorption (>93%), although limited solubility and potential hepatotoxicity were observed for several derivatives. Biological assays demonstrated significant antileishmanial activity. Interestingly, intracellular amastigote assays revealed nanomolar potency and very high selectivity index (SI), with compound 12 exhibiting IC 50 = 2.5 nM (SI = 21.030) and compound 9 IC 50 = 5.2 nM (SI = 7.384). Mechanistic studies demonstrated concentration‐dependent mitochondrial membrane depolarization and acidocalcisome alkalinization. Since these two organelles are both involved in bioenergetics and in parasite intracellular Ca 2+ homeostasis, the results support the notion that intracellular Ca 2+ disruption is an essential target for different drug actions. Overall, these findings support a multitarget mechanism and position these quinoline derivatives as promising chemical scaffolds for the development of improved antileishmanial strategies.
科研通智能强力驱动
Strongly Powered by AbleSci AI